REGENEPHRO

Currently, Osafune et al. have transferred the technology seeds described above to RegeNephro to suppress the occurrence of dialysis patients by suppressing the progress of CKD, improve the QOL of renal disease patients, and reduce the cost of dialysis medical treatment against renal diseases. We aim to realize new regenerative medicines using human iPS cells... Research and develop various solutions against kidney diseases,improve QOL among patients suffering from kidney diseases,and contribute to society 腎疾患に対する様々なソリューションを研究開発し、腎疾患に苦しむ患者さんのquality of Lifeの改善により社会に貢献する

Also known as: Rege Nephro Co., Ltd.

Primary location: Kyoto Japan